Disialosyl globopentaosylceramide (DSGb5) as a biomarker of prostate cancer

Akihiro Ito, Yoshihide Kawasaki, Narihiko Kakoi, Shuichi Shimada, Seiichi Saito, Yoichi Arai

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	196-200
Number of pages	5
Journal	Nippon rinsho. Japanese journal of clinical medicine
Volume	74
Publication status	Published - 2016 May 20

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

@article{f88237eb5d8e4aa7bd194e25438ce2ee,

title = "Disialosyl globopentaosylceramide (DSGb5) as a biomarker of prostate cancer",

author = "Akihiro Ito and Yoshihide Kawasaki and Narihiko Kakoi and Shuichi Shimada and Seiichi Saito and Yoichi Arai",

year = "2016",

month = may,

day = "20",

language = "English",

volume = "74",

pages = "196--200",

journal = "Nippon rinsho. Japanese journal of clinical medicine",

issn = "0047-1852",

publisher = "Nipponrinsho Co., Inc.",

}

TY - JOUR

T1 - Disialosyl globopentaosylceramide (DSGb5) as a biomarker of prostate cancer

AU - Ito, Akihiro

AU - Kawasaki, Yoshihide

AU - Kakoi, Narihiko

AU - Shimada, Shuichi

AU - Saito, Seiichi

AU - Arai, Yoichi

PY - 2016/5/20

Y1 - 2016/5/20

UR - http://www.scopus.com/inward/record.url?scp=85021856850&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85021856850&partnerID=8YFLogxK

M3 - Article

C2 - 27344728

AN - SCOPUS:85021856850

SN - 0047-1852

VL - 74

SP - 196

EP - 200

JO - Nippon rinsho. Japanese journal of clinical medicine

JF - Nippon rinsho. Japanese journal of clinical medicine

ER -